BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35182687)

  • 21. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
    Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
    Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac radiation dose distribution, cardiac events and mortality in early-stage lung cancer treated with stereotactic body radiation therapy (SBRT).
    Reshko LB; Kalman NS; Hugo GD; Weiss E
    J Thorac Dis; 2018 Apr; 10(4):2346-2356. PubMed ID: 29850140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
    Hahn E; Jiang H; Ng A; Bashir S; Ahmed S; Tsang R; Sun A; Gospodarowicz M; Hodgson D
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1116-1123. PubMed ID: 28721895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study.
    Walls GM; O'Connor J; Harbinson M; McCarron EP; Duane F; McCann C; McKavanagh P; Johnston DI; Erekkath J; Giacometti V; Gavin AT; McAleese J; Hounsell AR; Cole AJ; Butterworth KT; McGarry CK; Hanna GG; Jain S
    Radiother Oncol; 2023 Sep; 186():109762. PubMed ID: 37348608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric Planning Tradeoffs to Reduce Heart Dose Using Machine Learning-Guided Decision Support Software in Patients with Lung Cancer.
    Bitterman DS; Selesnick P; Bredfeldt J; Williams CL; Guthier C; Huynh E; Kozono DE; Lewis JH; Cormack RA; Carpenter CM; Mak RH; Atkins KM
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):996-1003. PubMed ID: 34774998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing cardiac doses: a novel multi-leaf collimator modification technique to reduce left anterior descending coronary artery dose in patients with left-sided breast cancer.
    Welsh B; Chao M; Foroudi F
    J Med Radiat Sci; 2017 Jun; 64(2):114-119. PubMed ID: 27741387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric Correlate of Cardiac-Specific Survival Among Patients Undergoing Coronary Artery Stenting After Thoracic Radiotherapy for Cancer.
    Sio TT; Liang JJ; Chang K; Jayakrishnan R; Novotny PJ; Prasad A; Miller RC
    Am J Clin Oncol; 2017 Apr; 40(2):133-139. PubMed ID: 25268066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breast.
    Mendez LC; Louie AV; Moreno C; Wronski M; Warner A; Leung E; Sakuraba R; Helito JK; Rezende A; Carvalho IT; Weltman E
    Radiat Oncol; 2018 Jul; 13(1):124. PubMed ID: 29973243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac substructures exposure in left-sided breast cancer radiotherapy: Is the mean heart dose a reliable predictor of cardiac toxicity?
    Naimi Z; Moujahed R; Neji H; Yahyaoui J; Hamdoun A; Bohli M; Kochbati L
    Cancer Radiother; 2021 May; 25(3):229-236. PubMed ID: 33423965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression models for predicting physical and EQD
    Wang H; Zhou Y; Gan W; Chen H; Huang Y; Duan Y; Feng A; Shao Y; Gu H; Kong Q; Xu Z
    Radiat Oncol; 2021 Jun; 16(1):119. PubMed ID: 34176503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
    Wijsman R; Dankers FJWM; Troost EGC; Hoffmann AL; van der Heijden EHFM; de Geus-Oei LF; Bussink J
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):434-441. PubMed ID: 28871994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes.
    Krueger EA; Schipper MJ; Koelling T; Marsh RB; Butler JB; Pierce LJ
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1195-203. PubMed ID: 15519792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
    Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
    J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
    Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
    Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac dose from tangential breast cancer radiotherapy in the year 2006.
    Taylor CW; Povall JM; McGale P; Nisbet A; Dodwell D; Smith JT; Darby SC
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):501-7. PubMed ID: 18374500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Low Endothelial Shear Stress and Plaque Characteristics in the Prediction of Nonculprit Major Adverse Cardiac Events: The PROSPECT Study.
    Stone PH; Maehara A; Coskun AU; Maynard CC; Zaromytidou M; Siasos G; Andreou I; Fotiadis D; Stefanou K; Papafaklis M; Michalis L; Lansky AJ; Mintz GS; Serruys PW; Feldman CL; Stone GW
    JACC Cardiovasc Imaging; 2018 Mar; 11(3):462-471. PubMed ID: 28917684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.